U.S. Semiconductors Stock News

NasdaqGM:NNOX
NasdaqGM:NNOXHealthcare

Nano-X Imaging (NNOX) Is Down 36.7% After 2025 Losses Deepen And New CFO Joins - Has The Bull Case Changed?

Nano-X Imaging’s April 2026 update showed fourth-quarter 2025 sales rising to US$3.72 million while net loss widened to US$33.37 million, including a US$17.53 million impairment, alongside full-year 2025 losses and the appointment of incoming CFO Guy Nathanzon after Ran Daniel’s planned departure. At the same time, a new clinical collaboration with Meir Medical Center to further validate the Nanox.ARC system highlights management’s focus on strengthening the technology’s real-world...
NasdaqGS:CATY
NasdaqGS:CATYBanks

Cathay General Bancorp (CATY) Q1 EPS Strength Reinforces Bulls’ High Margin Narrative

Cathay General Bancorp (CATY) opened 2026 with Q1 revenue of US$196.6 million and basic EPS of US$1.30, alongside net income of US$86.9 million. This followed a year in which trailing twelve month revenue reached US$769.6 million and EPS came in at US$4.86. Over the past year, revenue has moved from US$691.3 million to US$769.6 million on a trailing basis, while TTM EPS increased from US$3.97 to US$4.86. This gives investors a clearer view of how the latest quarter fits within a steadily...
NYSE:CXM
NYSE:CXMSoftware

Sprinklr’s Spring 2026 AI Push And CreatorIQ Alliance Test Investor Faith

Sprinklr (NYSE:CXM) has launched its Spring 2026 Release, introducing advanced AI-driven features for its customer experience platform. The release adds autonomous agent evaluation tools designed to assess and monitor AI performance in customer service. Sprinklr also announced a new alliance with CreatorIQ to integrate creator intelligence with its unified social media management capabilities. Sprinklr enters this product release cycle with its shares at $4.84 and a value score of 2,...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

AAD Pediatric Guideline Endorsement Puts Focus On Arcutis Growth Risks And Upside

ZORYVE (roflumilast) cream has received a strong, high certainty recommendation in the American Academy of Dermatology’s new pediatric atopic dermatitis guidelines. This is the AAD’s first set of clinical practice guidelines focused on pediatric atopic dermatitis, giving the product formal visibility in a key treatment area. The endorsement supports ZORYVE’s role as an evidence backed option for long term use in children with atopic dermatitis. For Arcutis Biotherapeutics (NasdaqGS:ARQT),...
NasdaqGS:HTLD
NasdaqGS:HTLDTransportation

Heartland Express (HTLD) Trailing Losses Of US$52.5 Million Test Bullish Profitability Narratives

Heartland Express (HTLD) opened 2026 with Q1 results that extend a run of soft profitability, capped by trailing 12 month revenue of US$805.7 million and a basic EPS loss of US$0.67 tied to a net loss of US$52.5 million. Over the past six reported quarters, quarterly revenue has ranged from US$179.4 million to US$259.9 million, while basic EPS has moved between a loss of US$0.02 and a loss of US$0.25. This sets up a story where investors are weighing ongoing losses against forecasts that...
NasdaqGS:MMLP
NasdaqGS:MMLPOil and Gas

Martin Midstream Partners (MMLP) Losses Challenge Bullish Valuation Narrative Ahead Of Q1 2026 Earnings

Martin Midstream Partners (MMLP) opened 2026 with Q1 results that keep the focus squarely on profitability, as the latest trailing 12 month figures show total revenue of US$716.1 million and a loss of US$14.4 million, or basic EPS of US$0.37. Over recent quarters, the partnership has seen quarterly revenue range from US$168.7 million to US$192.5 million, while basic EPS has moved between a profit of US$0.09 and losses of up to US$0.21. This sets up an earnings release where investors are...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Popular (BPOP) Net Margin Expansion Reinforces Bullish Efficiency Narrative Ahead Of Q1 2026

Popular (BPOP) has just posted another solid quarter, with Q4 2025 revenue of US$751.8 million and basic EPS of US$3.54, setting the tone as investors look at the new Q1 2026 reporting period. The bank has seen quarterly revenue move from US$689.4 million in Q4 2024 to US$751.8 million in Q4 2025, while basic EPS over that same stretch climbed from US$2.51 to US$3.54, giving you a clear sense of how the income line has scaled alongside the top line. Taken together with an improved net profit...
OTCPK:KTHN
OTCPK:KTHNBanks

Katahdin Bankshares (OTCPK:KTHN) Margin Improvement Challenges Long Term Earnings Slowdown Narrative

Katahdin Bankshares (KTHN) has just put another quarter on the board, with Q4 2025 revenue of US$11.9 million and basic EPS of US$0.99 setting the tone after a year in which trailing net income reached US$10.7 million on revenue of US$44.3 million. Over recent periods the company has seen revenue move from US$9.5 million and EPS of roughly US$0.56 in Q4 2024 to US$11.9 million and US$0.99 respectively in Q4 2025. Trailing basic EPS for the last reported twelve months reached about US$3.37...
OTCPK:ARBV
OTCPK:ARBVBanks

American Riviera Bancorp (OTCPK:ARBV) Net Profit Margin Improvement Challenges Bearish Earnings Narrative

American Riviera Bancorp (ARBV) opened 2026 with Q1 results that build on a solid finish to last year, with Q4 2025 revenue at about US$14.4 million and basic EPS of roughly US$0.80, while trailing twelve month revenue stood at about US$50.4 million and EPS at roughly US$2.18. Over recent quarters, revenue has moved from about US$10.7 million in Q4 2024 to US$14.4 million in Q4 2025, and basic EPS has shifted from roughly US$0.35 to US$0.80. This sets up a story where higher net income and...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Medpace (MEDP) Margin Slippage Challenges Bullish Narratives Despite Solid Q4 EPS

Medpace Holdings (MEDP) has followed up its recent run of strong results with Q4 2025 revenue of US$708.5 million and basic EPS of US$4.78, backing that up with trailing 12 month revenue of about US$2.5 billion and EPS of US$15.64. Over recent quarters the company has seen revenue move from US$533.3 million in Q3 2024 to US$708.5 million in Q4 2025, while quarterly basic EPS has ranged from US$3.11 to US$4.78 across the same stretch. With trailing net profit margins at 17.8% versus 19.2% the...
NYSE:MSB
NYSE:MSBMetals and Mining

Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives

Mesabi Trust (MSB) has put fresh FY 2026 numbers on the table, with third quarter revenue of US$3.6 million, basic EPS of US$0.21 and net income of US$2.8 million. The trust has seen quarterly revenue move between US$4.7 million and US$6.9 million and EPS range from US$0.28 to US$0.46 over the past year of reported periods, alongside net income between US$3.6 million and US$6.1 million. This sets a clear context for the latest print. With a trailing net margin of 82.8% and earnings quality...
NasdaqCM:FMAO
NasdaqCM:FMAOBanks

Farmers & Merchants Bancorp (FMAO) Net Interest Margin Improvement Tests Bullish Community Narratives

Farmers & Merchants Bancorp (FMAO) has put fresh numbers on the board, with Q4 2025 revenue of about US$31.9 million and basic EPS of US$0.70, supported by net income of US$9.7 million as the latest marker ahead of its Q1 2026 reporting period. The business has seen revenue move from US$26.6 million and EPS of US$0.59 in Q4 2024 to US$31.9 million and EPS of US$0.70 in Q4 2025. Trailing 12 month earnings growth of 29.4% and a 27.6% net margin frame a profitability profile that many investors...
NasdaqGM:SMBC
NasdaqGM:SMBCBanks

Southern Missouri Bancorp (SMBC) Net Interest Margin Holds At 3.57% Reinforcing Growth Narrative

Southern Missouri Bancorp (SMBC) opened Q3 2026 with Q2 results that put revenue and earnings in clear focus, reporting total revenue of US$48.0 million and basic EPS of US$1.62 on net income of US$18.1 million. The company has seen revenue move from US$41.7 million with EPS of US$1.10 in Q1 2025 to US$45.1 million and EPS of US$1.40 in Q4 2025, then to US$48.0 million and EPS of US$1.62 in Q2 2026. This latest report can be viewed as part of a steady earnings story that investors can now...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher Scientific (TMO) Margin Hold At 15% Tests Long Term Earnings Concerns

Thermo Fisher Scientific (TMO) has just put fresh numbers on the table, with Q4 2025 revenue of US$12.2b and basic EPS of US$5.22 setting the tone against a trailing twelve month EPS of US$17.78 on revenue of US$44.6b, alongside net income of US$6.7b. The company has seen quarterly revenue move from US$10.6b in Q3 2024 to US$12.2b in Q4 2025, while basic EPS over the same period went from US$4.27 to US$5.22. This gives investors a clear read on top line scale and earnings power as they assess...
NasdaqGS:KRNY
NasdaqGS:KRNYBanks

Kearny Financial (KRNY) Net Interest Margin Near 2.1% Challenges Bearish Narratives

Kearny Financial (KRNY) has just reported Q3 2026 results with quarterly revenue in the low US$40 million range and basic EPS of about US$0.15, set against a trailing twelve month EPS of US$0.52 that reflects the shift back into profitability. Over recent periods, revenue has moved from US$36.96 million in Q1 2025 to US$42.97 million in Q2 2026, while quarterly EPS has stepped from roughly US$0.10 to just over US$0.15. This gives investors a clearer read on how earnings now sit relative to...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

First Bancorp (FBNC) Q1 Net Income Rebound Tests Bearish Regional Bank Narratives

First Bancorp (FBNC) opened 2026 with Q1 results that put the focus squarely on the income statement, reporting total revenue of US$119.2 million and basic EPS of US$1.13, backed by trailing twelve month revenue of US$393.3 million and EPS of US$2.93. Over recent periods the company has seen quarterly revenue move from US$65.2 million in Q4 2024 to US$104.7 million in Q1 2025, US$108.8 million in Q2, US$86.2 million in Q3 and US$79.2 million in Q4, while EPS shifted from US$0.09 to US$0.88,...
NYSE:DOV
NYSE:DOVMachinery

Dover (DOV) Margin Reset To 13.6% Tests Quality Growth Narrative Heading Into Q1 2026

Dover (DOV) kicked off Q1 2026 against a backdrop of recent quarterly revenue between US$1.87 billion and US$2.10 billion and basic EPS ranging from US$1.74 to US$2.21 through 2025, with trailing 12 month revenue at about US$8.09 billion and EPS at US$8.01. Over that same trailing period, revenue has stayed in a tight band around US$7.72 billion to US$8.09 billion, while EPS moved between US$7.55 and US$8.01. This provides a clear sense of how top line and per share earnings have been...
NYSE:ESE
NYSE:ESEMachinery

Is It Too Late To Consider ESCO Technologies (ESE) After A 102% One Year Rally?

Wondering whether ESCO Technologies at around US$318.83 still offers value, or if most of the opportunity is already reflected in the price. The stock has posted returns of 6.3% over the last week, 15.2% over the past month, 61.3% year to date and 102.2% over the past year, with a 3 year return of 242.0% and 5 year return of 190.3%. Recent coverage has focused on ESCO Technologies as a capital goods player whose share price performance has drawn fresh attention from investors seeking quality...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX (CSX) Margin Compression Challenges Bullish Narratives Heading Into Q1 2026 Earnings

CSX (CSX) has just opened its 2026 reporting year with investors still focused on the recent Q4 2025 numbers, where revenue came in at US$3.5b and basic EPS was US$0.39, setting the reference point for how Q1 performance will be judged. Over the past few quarters, revenue has held in a tight band around US$3.4b to US$3.6b, while basic EPS moved between US$0.34 and US$0.44, giving a clear read on how small shifts in volumes and pricing flow through to earnings. With trailing net margins at...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

QCR Holdings (QCRH) Net Margin Strength Challenges Cautious Earnings Narratives Heading Into Q1 2026

QCR Holdings (QCRH) just wrapped up Q1 2026 with recent quarterly revenue running around US$101.5 million and basic EPS of about US$2.13, backed by trailing twelve month revenue of roughly US$351.5 million and EPS of US$7.54 that has been associated with an 11.7% earnings growth rate over the past year. Over recent periods, the company has seen revenue move from US$330.2 million and EPS of US$6.77 on a trailing basis in Q4 2024 to US$351.5 million and EPS of US$7.54 by Q4 2025, supported by a...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

CVB Financial (CVBF) Net Interest Margin At 3.44% Backs Bullish Profitability Narratives

CVB Financial (CVBF) opened 2026 with Q1 numbers that keep the focus squarely on profitability, with trailing 12 month EPS at US$1.52 on total revenue of US$518.96 million and net income of US$207.92 million. The company has seen revenue move from US$504.82 million to US$518.96 million over the past year, while trailing EPS shifted from US$1.44 to US$1.52, setting up this quarter against a backdrop of slightly higher margins and earnings. See our full analysis for CVB Financial. With the...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

WillScot’s Great Place To Work Streak And What It Means For Investors

WillScot Holdings (NasdaqCM:WSC) has been certified as a Great Place to Work® for the fourth consecutive year. The recognition is based on employee feedback about workplace culture, safety, and support. This ongoing certification highlights WillScot's focus on employee engagement and organizational health. WillScot, which provides modular space and portable storage solutions, is operating in an industry where execution, safety, and on site reliability matter to customers. A consistent Great...
NasdaqGS:THRM
NasdaqGS:THRMAuto Components

Gentherm (THRM) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue

Gentherm (THRM) has opened Q1 2026 earnings season with recent quarterly numbers that show total revenue at about US$382.8 million in Q4 2025 and basic EPS of roughly US$0.10, following earlier quarters that ranged from a small loss to stronger profitability. Over the last six reported quarters, revenue has moved between US$352.9 million and US$386.9 million while basic EPS has ranged from a small loss of roughly US$0.00 per share in early 2025 to about US$0.51 per share in several 2024 and...
NYSE:PCG
NYSE:PCGElectric Utilities

PG&E (PCG) Margin Stability And Slower Earnings Growth Test Bullish Narratives

PG&E (PCG) has kicked off Q1 2026 with recent quarterly revenue of about US$6.8 billion and basic EPS of US$0.29, set against a trailing twelve month EPS of US$1.18 and net income of US$2.6 billion. Together, these figures frame the scale of its earnings power. Over recent quarters, revenue has moved from US$6.0 billion in Q1 2025 to US$6.3 billion in Q3 and US$6.8 billion in Q4, while quarterly EPS has ranged between US$0.24 and US$0.37 over that stretch. This gives investors a clear view of...